Biliary tract cancer is increasing in incidence and mortality across Europe, with more people under the age of 60 years old ...
C3i became the first contract development and manufacturing organization (CDMO) for cell and gene therapies in Canada to ...
Global biotechnology leader CSL (ASX: CSL; USOTC: CSLLY) and sa-mRNA pioneer Arcturus Therapeutics (Nasdaq: ARCT) today ...
Belgian MEP Liesbet Sommen spoke with Euractiv about critical medicines shortages, EU Pharma Package progress, and SANT's evolving role.
Gilead Sciences (GILD) said on Friday that the European Commission (EC) granted conditional marketing authorization for ...
CSL (CSLLY) and Arcturus Therapeutics (ARCT) announced that the European Commission has granted marketing authorization for Kostaive, a ...
CATUMAXOMAB BECOMES THE ONLY APPROVED DRUG THERAPY FOR MALIGNANT ASCITES, A RARE AND DEBILITATING COMPLICATION OF ADVANCED-STAGE CANCER UNDER A LICENSING AGREEM ...
Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd., today announced that the European Commission (EC) granted marketing authorisation in the ...
The study highlights the need to address inefficiencies and rising costs, calling for improved collaboration with the European Medicines Agency (EMA) and national authorities. “This study provides ...
The European Medicines Agency (EMA) said on Monday it would no longer post on X and would use rival Bluesky instead, becoming the latest organisation to quit a social media platform that some have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results